subject to

subject to. (a) this Agreement recognizes the grant of a research license and options to commercial licenses covering the Patent Rights within the Pfizer Licenses; and (b) that the Pfizer Licenses provide an exclusive right to make, use and sell KUCD with pharmaceutical products indicated for use in the treatment and prophylaxis of fungal infections in humans; and (c) that the Pfizer Licenses grant Pfizer a non-exclusive option to a non-exclusive worldwide license, within certain terms and conditions, to... make, use or sell KUCD with known Pfizer compounds or new chemical entities discovered or obtained by Pfizer for use in humans except for use in ophthalmic and nasal formulations. View More